3/10
05:27 pm
ango
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference [Yahoo! Finance]
Medium
Report
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference [Yahoo! Finance]
3/10
04:30 pm
ango
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
Medium
Report
AngioDynamics to Present at the Oppenheimer 35th Annual Healthcare MedTech and Services Virtual Conference
3/4
07:07 am
ango
Tumor Ablation Market to Reach $7.5 billion, Globally, by 2035 at 13.6% CAGR: Allied Market Research [Yahoo! Finance]
Low
Report
Tumor Ablation Market to Reach $7.5 billion, Globally, by 2035 at 13.6% CAGR: Allied Market Research [Yahoo! Finance]
2/24
07:42 am
ango
Several Insiders Invested In AngioDynamics Flagging Positive News [Yahoo! Finance]
Medium
Report
Several Insiders Invested In AngioDynamics Flagging Positive News [Yahoo! Finance]
1/31
10:54 am
ango
ANGO Stock Looks Promising on New Ischemia Study for Auryon System [Yahoo! Finance]
Medium
Report
ANGO Stock Looks Promising on New Ischemia Study for Auryon System [Yahoo! Finance]
1/30
08:03 am
ango
Yahoo Finance [Yahoo! Finance]
Low
Report
Yahoo Finance [Yahoo! Finance]
1/30
07:30 am
ango
AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia
Low
Report
AngioDynamics Initiates AMBITION BTK RCT and Registry to Advance Treatment for Critical Limb Ischemia
1/21
08:13 am
ango
Endorectal Balloon Market to Witness Remarkable Growth, Reaching US$ 549.7 Million by 2034 at a Strong CAGR of 9.9% | Fact.MR Report [Yahoo! Finance]
Medium
Report
Endorectal Balloon Market to Witness Remarkable Growth, Reaching US$ 549.7 Million by 2034 at a Strong CAGR of 9.9% | Fact.MR Report [Yahoo! Finance]
1/13
08:00 am
ango
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
Medium
Report
AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI
1/10
08:36 am
ango
AngioDynamics, Inc. (NASDAQ: ANGO) had its price target raised by analysts at HC Wainwright from $14.00 to $15.00. They now have a "buy" rating on the stock.
Low
Report
AngioDynamics, Inc. (NASDAQ: ANGO) had its price target raised by analysts at HC Wainwright from $14.00 to $15.00. They now have a "buy" rating on the stock.
1/8
06:30 am
ango
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
High
Report
AngioDynamics Reports Fiscal Year 2025 Second Quarter Financial Results
1/7
07:41 am
ango
Anaconda Biomed Appoints Trent Reutiman New CEO [Yahoo! Finance]
Low
Report
Anaconda Biomed Appoints Trent Reutiman New CEO [Yahoo! Finance]
1/6
09:26 am
ango
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
Low
Report
AngioDynamics to Present at the J.P. Morgan Healthcare Conference
1/6
09:25 am
ango
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System
Low
Report
AngioDynamics to Host Virtual Event Showcasing the Innovative NanoKnife™ System
12/19
05:00 pm
ango
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event
Medium
Report
AngioDynamics to Report Fiscal 2025 Second Quarter Financial Results on January 8, 2025 and Host Virtual NanoKnife Investor Event